Meta approaches publishers about licensing articles for artificial intelligence tools

Meta is in discussions with publishers including Axel Springer, Fox Corp. and News Corp to license articles for its artificial intelligence tools. Details such as deal terms, scope and timelines were not stated.

Meta Platforms is reportedly in discussions with several major media companies to secure licenses for articles that would be used in connection with the companyu2019s artificial intelligence tools. The outreach includes publishers named in the report such as Axel Springer, Fox Corp. and News Corp., signaling that Meta is engaging established news organizations rather than only independent outlets.

The conversations focus on licensing written content from those publishers for use with Metau2019s artificial intelligence capabilities. The article lists the companies contacted but does not provide further detail on the nature of the proposed arrangements, whether they would cover specific titles or categories of content, or how broadly the licenses would be applied across Metau2019s products.

Key specifics about the talks were not provided in the scraped article. Information not stated includes the financial terms of any potential agreements, the intended uses of licensed material within Metau2019s artificial intelligence systems, the timeline for negotiations, whether any deals have been signed, and responses from the named publishers. The scraped page also did not include additional context, statements from the parties, or reporting beyond the brief named-company list and the licensing intent. Not stated.

50

Impact Score

HMS researchers design Artificial Intelligence tool to quicken drug discovery

Harvard Medical School researchers unveiled PDGrapher, an Artificial Intelligence tool that identifies gene target combinations to reverse disease states up to 25 times faster than current methods. The Nature-published study outlines a shift from single-target screening to multi-gene intervention design.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.